APOA1 and diabetes mellitus: Both lipid-free and lipid-associated forms of apoA-I and apoA-II increase insulin synthesis and glucose-stimulated insulin secretion by upregulating the expression of Pdx1, thereby preserving β-cell function and reducing the harmful effects of activated T-cells in diabetes (37).